Contineum Therapeutics, Inc. (CTNM)
17.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
17.04
0.00 (0.00%)
After-Hours: 19:10
Contineum Therapeutics Total Assets (Quarterly) : 250.37M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 250.37M |
| March 31, 2026 | 261.35M |
| December 31, 2025 | 278.38M |
| September 30, 2025 | 190.85M |
| June 30, 2025 | 182.89M |
| March 31, 2025 | 198.26M |
| December 31, 2024 | 212.85M |
| September 30, 2024 | 216.03M |
| Date | Value |
|---|---|
| June 30, 2024 | 221.36M |
| March 31, 2024 | 123.56M |
| December 31, 2023 | 130.39M |
| September 30, 2023 | 139.04M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 50.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.71M |
| Shareholders Equity (Quarterly) | 239.66M |
| Debt to Equity Ratio | 0.0274 |
| Current Ratio | 37.17 |
| Net Debt Paydown Yield | -0.02% |